Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

DRAD Insider Trading

DRAD | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at DRAD provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2020-12-02 01:16 2020-11-30 Noble David J. Officer - COO; CFO SELL $2.97 3,000 $8,910 50,478 -5.6%
2020-11-21 02:07 2020-11-18 Eberwein Jeffrey E. Director BUY $2.50 20,000 $49,928 157,213 +14.6%
2020-06-16 02:59 2020-06-11 Eberwein Jeffrey E. Director SELL $7.91 1,514 $11,976 845,412 -0.2%
2020-05-30 02:59 2020-05-28 Noble David J. Officer - COO; CFO BUY $2.24 20,000 $44,800 51,562 +63.4%
2020-05-30 02:47 2020-05-28 Cunnion Michael A. Director BUY $2.24 5,000 $11,200 15,047 +49.8%
2020-05-30 02:52 2020-05-28 Eberwein Jeffrey E. Director BUY $2.24 44,000 $98,560 135,963 +47.8%
2020-05-30 02:57 2020-05-28 Molchan Matthew G. Director, Officer - President and CEO BUY $2.24 2,000 $4,480 27,735 +7.8%
2020-05-30 03:03 2020-05-28 QUAIN MITCHELL I Director BUY $2.24 22,000 $49,280 42,478 +107.4%
2019-11-25 17:58 2019-11-20 CANNELL CAPITAL LLC 10% owner SELL $3.19 20,293 $64,666 202,826 -9.1%
2019-09-12 23:46 2019-09-10 Eberwein Jeffrey E. Director BUY $10.00 300,000 $3,000,000 300,000 +100.0%
2019-05-20 22:30 2019-05-20 Noble David J. Officer - COO; Interim CFO BUY $0.64 30,000 $19,200 205,000 +17.1%
2019-05-17 23:06 2019-05-17 Noble David J. Officer - COO; Interim CFO BUY $0.65 8,538 $5,550 175,000 +5.1%
2019-05-17 03:04 2019-05-15 Eberwein Jeffrey E. Director BUY $0.68 40,000 $27,200 869,152 +4.8%
2019-05-17 04:19 2019-05-15 QUAIN MITCHELL I Director BUY $0.75 38,000 $28,378 3,000 +100.0%
2019-05-15 03:58 2019-05-13 Eberwein Jeffrey E. Director BUY $0.67 10,000 $6,680 829,152 +1.2%
2019-05-15 04:17 2019-05-13 QUAIN MITCHELL I Director BUY $0.68 69,000 $46,920 166,803 +70.5%
2019-05-10 02:46 2019-05-08 Eberwein Jeffrey E. Director BUY $0.69 260,000 $178,594 819,152 +46.5%
2019-03-19 23:14 2019-03-15 Cunnion Michael A. Director BUY $0.80 16,242 $12,994 49,992 +48.1%
2019-03-18 23:51 2019-03-15 Noble David James Officer - COO; Interim CFO BUY $0.82 40,000 $32,800 75,000 +114.3%
2019-03-19 03:26 2019-03-15 Climaco John M Director BUY $0.82 6,000 $4,920 56,600 +11.9%
2019-03-19 03:29 2019-03-15 Molchan Matthew G. Director, Officer - President and CEO BUY $0.85 20,000 $17,000 162,396 +14.0%
2019-03-19 03:33 2019-03-15 QUAIN MITCHELL I Director BUY $0.76 97,803 $74,330 97,803 +100.0%
2019-03-15 23:45 2019-03-15 Eberwein Jeffrey E. Director BUY $0.74 15,000 $11,100 559,152 +2.8%
2018-11-17 02:21 2018-11-15 Noble David James Officer - Chief Operating Officer BUY $1.05 15,842 $16,663 35,000 +82.7%
2018-11-13 17:00 2018-11-09 Eberwein Jeffrey E. Director BUY $1.15 25,000 $28,750 544,152 +4.8%
2018-09-13 00:17 2018-09-10 CANNELL CAPITAL LLC 10% owner BUY $1.75 68,594 $120,108 2,231,136 +3.2%
2018-09-11 00:56 2018-09-06 CANNELL CAPITAL LLC 10% owner BUY $1.74 800 $1,388 2,162,542 +0.0%
2018-05-25 23:06 2018-05-23 Lott Virgil Officer - President, Diagnostic Imaging OPT+S $1.75 200 $350 69,454 0.0%
2018-03-02 03:48 2018-02-28 Molchan Matthew G. Director, Officer - President and CEO BUY $2.14 25,000 $53,500 99,079 +33.7%
2018-01-26 01:48 2018-01-23 CANNELL CAPITAL LLC 10% owner BUY $2.65 65,508 $173,858 2,161,742 +3.1%
2017-12-30 00:46 2017-12-28 CANNELL CAPITAL LLC 10% owner SELL $2.99 8,300 $24,816 2,096,234 -0.4%
2017-09-07 23:33 2017-09-05 Keyes Jeffry R. Officer - Chief Financial Officer BUY $3.47 1,450 $5,032 39,318 +3.8%
2017-08-11 00:08 2017-08-09 Cunnion Michael A. Director SELL $3.80 3,750 $14,250 21,250 -15.0%
2016-12-16 01:14 2016-12-13 Lott Virgil Officer - President, Diagnostic Imaging OPT+S $4.40 40,000 $176,000 54,909 0.0%
2016-11-15 02:08 2016-11-09 Molchan Matthew G. Director, Officer - President and CEO OPT+S $4.62 18,066 $83,541 44,267 0.0%
2016-11-04 23:28 2016-11-03 Keyes Jeffry R. Officer - Chief Financial Officer BUY $4.23 2,000 $8,450 30,715 +7.0%
2016-10-22 00:43 2016-09-12 Eberwein Jeffrey E. Director BUY $5.01 1,145 $5,732 997,513 +0.1%
2016-09-16 02:39 2016-09-13 Eberwein Jeffrey E. Director BUY $5.00 5,625 $28,145 70,000 +8.7%
2016-09-15 03:22 2016-09-12 Eberwein Jeffrey E. Director BUY $5.01 1,245 $6,233 997,513 +0.1%
2016-08-26 01:42 2016-08-22 Eberwein Jeffrey E. Director BUY $5.01 300 $1,503 996,891 +0.0%
2016-08-20 01:52 2016-08-17 Eberwein Jeffrey E. Director BUY $5.00 28,482 $142,518 996,754 +2.9%
2016-08-16 02:40 2016-08-11 Eberwein Jeffrey E. Director BUY $5.00 18,394 $91,964 983,766 +1.9%
2016-06-10 23:17 2016-06-08 Lott Virgil Officer - President, Diagnostic Imaging OPT+S $5.25 23,333 $122,498 54,909 0.0%
2016-06-10 02:34 2016-06-07 Eberwein Jeffrey E. Director BUY $4.99 1,846 $9,212 975,366 +0.2%
2016-06-07 01:35 2016-06-02 Eberwein Jeffrey E. Director BUY $5.01 25,943 $129,845 974,524 +2.7%
2016-06-02 00:47 2016-05-27 Eberwein Jeffrey E. Director BUY $5.00 6,700 $33,509 962,680 +0.7%
2016-06-01 23:45 2016-05-27 Molchan Matthew G. Director, Officer - President and CEO OPT+S $5.01 5,833 $29,222 32,333 0.0%
2016-04-08 02:45 2016-04-05 Eberwein Jeffrey E. Director BUY $4.91 11,700 $57,476 959,625 +1.2%
2016-04-05 02:22 2016-03-31 Eberwein Jeffrey E. Director BUY $4.97 17,000 $84,454 954,318 +1.8%
2016-03-25 02:50 2016-03-22 Eberwein Jeffrey E. Director BUY $4.96 8,340 $41,325 946,578 +0.9%
SHOW ENTRIES

How to Interpret $DRAD Trades

Not every insider transaction in DRAD is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $DRAD shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for DRAD

Insider activity data for DRAD is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $DRAD, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.